160 related articles for article (PubMed ID: 16995875)
1. Potential role of natural killer cells in controlling growth and infiltration of AIDS-associated primary effusion lymphoma cells.
Dewan MZ; Terunuma H; Toi M; Tanaka Y; Katano H; Deng X; Abe H; Nakasone T; Mori N; Sata T; Yamamoto N
Cancer Sci; 2006 Dec; 97(12):1381-7. PubMed ID: 16995875
[TBL] [Abstract][Full Text] [Related]
2. Role of natural killer cells in hormone-independent rapid tumor formation and spontaneous metastasis of breast cancer cells in vivo.
Dewan MZ; Terunuma H; Takada M; Tanaka Y; Abe H; Sata T; Toi M; Yamamoto N
Breast Cancer Res Treat; 2007 Sep; 104(3):267-75. PubMed ID: 17066321
[TBL] [Abstract][Full Text] [Related]
3. Rapid tumor formation of human T-cell leukemia virus type 1-infected cell lines in novel NOD-SCID/gammac(null) mice: suppression by an inhibitor against NF-kappaB.
Dewan MZ; Terashima K; Taruishi M; Hasegawa H; Ito M; Tanaka Y; Mori N; Sata T; Koyanagi Y; Maeda M; Kubuki Y; Okayama A; Fujii M; Yamamoto N
J Virol; 2003 May; 77(9):5286-94. PubMed ID: 12692230
[TBL] [Abstract][Full Text] [Related]
4. Proliferation of functional human natural killer cells with anti-HIV-1 activity in NOD/SCID/Jak3(null) mice.
Hattori S; Matsuda K; Kariya R; Harada H; Okada S
Microbiol Immunol; 2016 Feb; 60(2):106-13. PubMed ID: 26708420
[TBL] [Abstract][Full Text] [Related]
5. Establishment of a primary effusion lymphoma cell line (RM-P1) and in vivo growth system using SCID mice.
Miyagi J; Masuda M; Takasu N; Nagasaki A; Shinjyo T; Uezato H; Kakazu N; Tanaka Y
Int J Hematol; 2002 Aug; 76(2):165-72. PubMed ID: 12215016
[TBL] [Abstract][Full Text] [Related]
6. Continuously expanding CAR NK-92 cells display selective cytotoxicity against B-cell leukemia and lymphoma.
Oelsner S; Friede ME; Zhang C; Wagner J; Badura S; Bader P; Ullrich E; Ottmann OG; Klingemann H; Tonn T; Wels WS
Cytotherapy; 2017 Feb; 19(2):235-249. PubMed ID: 27887866
[TBL] [Abstract][Full Text] [Related]
7. Primary human immunodeficiency virus type 1 viremia and central nervous system invasion in a novel hu-PBL-immunodeficient mouse strain.
Koyanagi Y; Tanaka Y; Kira J; Ito M; Hioki K; Misawa N; Kawano Y; Yamasaki K; Tanaka R; Suzuki Y; Ueyama Y; Terada E; Tanaka T; Miyasaka M; Kobayashi T; Kumazawa Y; Yamamoto N
J Virol; 1997 Mar; 71(3):2417-24. PubMed ID: 9032379
[TBL] [Abstract][Full Text] [Related]
8. Immunodeficient mouse strains display marked variability in growth of human melanoma lung metastases.
Carreno BM; Garbow JR; Kolar GR; Jackson EN; Engelbach JA; Becker-Hapak M; Carayannopoulos LN; Piwnica-Worms D; Linette GP
Clin Cancer Res; 2009 May; 15(10):3277-86. PubMed ID: 19447870
[TBL] [Abstract][Full Text] [Related]
9. Lymphoma cell lines: in vitro models for the study of HHV-8+ primary effusion lymphomas (body cavity-based lymphomas).
Drexler HG; Uphoff CC; Gaidano G; Carbone A
Leukemia; 1998 Oct; 12(10):1507-17. PubMed ID: 9766492
[TBL] [Abstract][Full Text] [Related]
10. Natural killer cells in breast cancer cell growth and metastasis in SCID mice.
Dewan MZ; Terunuma H; Ahmed S; Ohba K; Takada M; Tanaka Y; Toi M; Yamamoto N
Biomed Pharmacother; 2005 Oct; 59 Suppl 2():S375-9. PubMed ID: 16507413
[TBL] [Abstract][Full Text] [Related]
11. Role of natural killer cells on engraftment of human lymphoid cells and on metastasis of human T-lymphoblastoid leukemia cells in C57BL/6J-scid mice and in C57BL/6J-scid bg mice.
Christianson SW; Greiner DL; Schweitzer IB; Gott B; Beamer GL; Schweitzer PA; Hesselton RM; Shultz LD
Cell Immunol; 1996 Aug; 171(2):186-99. PubMed ID: 8806787
[TBL] [Abstract][Full Text] [Related]
12. Natural killer cell depletion by anti-asialo GM1 antiserum treatment enhances human hematopoietic stem cell engraftment in NOD/Shi-scid mice.
Yoshino H; Ueda T; Kawahata M; Kobayashi K; Ebihara Y; Manabe A; Tanaka R; Ito M; Asano S; Nakahata T; Tsuji K
Bone Marrow Transplant; 2000 Dec; 26(11):1211-6. PubMed ID: 11149733
[TBL] [Abstract][Full Text] [Related]
13. Regulation of human cell engraftment and development of EBV-related lymphoproliferative disorders in Hu-PBL-scid mice.
Wagar EJ; Cromwell MA; Shultz LD; Woda BA; Sullivan JL; Hesselton RM; Greiner DL
J Immunol; 2000 Jul; 165(1):518-27. PubMed ID: 10861091
[TBL] [Abstract][Full Text] [Related]
14. Antitumor Effect of Programmed Death-1 (PD-1) Blockade in Humanized the NOG-MHC Double Knockout Mouse.
Ashizawa T; Iizuka A; Nonomura C; Kondou R; Maeda C; Miyata H; Sugino T; Mitsuya K; Hayashi N; Nakasu Y; Maruyama K; Yamaguchi K; Katano I; Ito M; Akiyama Y
Clin Cancer Res; 2017 Jan; 23(1):149-158. PubMed ID: 27458246
[TBL] [Abstract][Full Text] [Related]
15. Highly activated and expanded natural killer cells for multiple myeloma immunotherapy.
Garg TK; Szmania SM; Khan JA; Hoering A; Malbrough PA; Moreno-Bost A; Greenway AD; Lingo JD; Li X; Yaccoby S; Suva LJ; Storrie B; Tricot G; Campana D; Shaughnessy JD; Nair BP; Bellamy WT; Epstein J; Barlogie B; van Rhee F
Haematologica; 2012 Sep; 97(9):1348-56. PubMed ID: 22419581
[TBL] [Abstract][Full Text] [Related]
16. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells.
Shultz LD; Lyons BL; Burzenski LM; Gott B; Chen X; Chaleff S; Kotb M; Gillies SD; King M; Mangada J; Greiner DL; Handgretinger R
J Immunol; 2005 May; 174(10):6477-89. PubMed ID: 15879151
[TBL] [Abstract][Full Text] [Related]
17. Engraftment and tumorigenesis of HTLV-1 transformed T cell lines in SCID/bg and NOD/SCID mice.
Liu Y; Dole K; Stanley JR; Richard V; Rosol TJ; Ratner L; Lairmore M; Feuer G
Leuk Res; 2002 Jun; 26(6):561-7. PubMed ID: 12007504
[TBL] [Abstract][Full Text] [Related]
18. Regulation of human short-term repopulating cell (STRC) engraftment in NOD/SCID mice by host CD122+ cells.
Shultz LD; Banuelos SJ; Leif J; Appel MC; Cunningham M; Ballen K; Burzenski L; Greiner DL
Exp Hematol; 2003 Jun; 31(6):551-8. PubMed ID: 12829032
[TBL] [Abstract][Full Text] [Related]
19. Selective expansion and engraftment of human CD16+ NK cells in NOD/SCID mice.
Harada H; Suzu S; Ito T; Okada S
Eur J Immunol; 2005 Dec; 35(12):3599-609. PubMed ID: 16304638
[TBL] [Abstract][Full Text] [Related]
20. Engraftment of human T, B and NK cells in CB.17 SCID/beige mice by transfer of human spleen cells.
Yacoub-Youssef H; Marcheix B; Calise D; Thiers JC; Therville N; Benoist H; Blaes N; Ségui B; Dambrin C; Thomsen M
Transpl Immunol; 2005 Dec; 15(2):157-64. PubMed ID: 16412960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
